Medicenna Therapeutics Corp (MDNAF)
OTCMKTS: MDNAF · Delayed Price · USD
1.410
+0.015 (1.08%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Medicenna Therapeutics Employees
Medicenna Therapeutics had 16 employees as of March 31, 2024. The number of employees did not change compared to the previous year.
Employees
16
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$547,188
Market Cap
105.44M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
| Danaher | 63,000 |
MDNAF News
- 25 days ago - Medicenna Therapeutics Reports Fiscal Year 2024 Financial Results and Operational Highlights - GlobeNewsWire
- 26 days ago - Medicenna Announces EMA Approval of its Clinical Trial Application to Expand its Phase 1/2 ABILITY-1 Study to Europe - GlobeNewsWire
- 7 weeks ago - Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeting - GlobeNewsWire
- 7 weeks ago - Medicenna To Present Evidence of Durable Single Agent Activity and Potent Immune Effector Response with MDNA11 in the Dose Escalation Portion of Phase 1/2 ABILITY-1 Study at the 10th Annual Oncology Innovation Forum - GlobeNewsWire
- 2 months ago - Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual Oncology Innovation Forum - GlobeNewsWire
- 2 months ago - Medicenna Provides Update on its Presentations at the 2024 ASCO Annual Meeting - GlobeNewsWire
- 2 months ago - Medicenna Therapeutics Announces Closing of CA$20 Million Investment from RA Capital Management - GlobeNewsWire
- 3 months ago - Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management - GlobeNewsWire